Upload File

taimed biologicsir.taimedbiologics.com/financial/55/en/20190503114506-2.pdf107 106+1 h la £ 12 h 31...

  • Home
  • Documents
  • TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
75

Upload: others

Post on 12-Oct-2020

2 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 2: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 3: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 4: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 5: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 6: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 7: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 8: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 9: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 10: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 11: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 12: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 13: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 14: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 15: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 16: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 17: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 18: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 19: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 20: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 21: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 22: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 23: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 24: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 25: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 26: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 27: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 28: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 29: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 30: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 31: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 32: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 33: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 34: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 35: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 36: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 37: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 38: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 39: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 40: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 41: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 42: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 43: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 44: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 45: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 46: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 47: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 48: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 49: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 50: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 51: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 52: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 53: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 54: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 55: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 56: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 57: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 58: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 59: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 60: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 61: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 62: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 63: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 64: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 65: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 66: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 67: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 68: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 69: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 70: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 71: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 72: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 73: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 74: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090
Page 75: TaiMed Biologicsir.taimedbiologics.com/financial/55/EN/20190503114506-2.pdf107 106+1 h la £ 12 h 31 a ($ 321,710) 74,394) 138,838 16,883 46,026 21,321 17,873) 20,173 5,784) 182,090

the compelling alternative...Orbis Operating Budget 16,883 15,923 BHCC Operating Budget 3,757 3,498 20,640 19,420 SCC MoBo Budget 12,513 12,531 ESCC MoBo Budget 579 551 BHCC MoBo Budget

野村グローバルREITプレミアム （通貨セレクト …...2019/02/07  · 68期(2018年1月9日) 8,727 80 3.6 0.0 － 98.7 20,173 69期(2018年2月7日) 7,886 80 8.7 0.0

Plaza 100 - Gardner Commercial Realty · 2020 Avg Household Income $145,227 $138,838 $134,337 2020 Med Household Income $118,465 $111,722 $108,448. Demographic Summary Report. Plaza

第43 期 第2四半期報告書 - nicera.co.jpnicera.co.jp/ir/pdf/ir-201706_2.pdf · 売上高 10,276 9,685 9,824 20,173 19,525 20,000 2015年 2016年 2017年 第2四半期 9,824百万円

PT TOYOTA ASTRA FINANCIAL SERVICES · Lindung nilai arus kas 2p (197,606) 137,222 (138,838) 111,356 Cash flow hedge Kerugian aktuarial program Actuarial loss from pensiun - (331)

Released for publication Sunday mornings July 9, IQlS. Not ... · PDF filecen , warrants 14*5 P^r cent, ... Chargeable to F. R. Agent 16,883 86,860 11,880 13,387 13,049 18,094 8,514

JOURNALISM OF COURAGE · 7.09 DETECTEDTODAY 22,752 RECOVEREDTODAY: 16,883 TOTAL CASES 2,17,121 1,02,831 1,18,594 17,999 27,612 DOUBLING RATE** 22.86 ... OFCOVID-19 Lotsofthingscouldbe

Key messages Food security outlook Humanitarian needs · 138,838 children reached with life-saving humanitarian assistance in November 2018 Reporting period November 01- November

RETAIL PROPERTY FOR SALE WINDCHASE SHOPPING CENTER...AVERAGE HOUSE VALUE $138,838 $120,838 $131,627 COLUMBUS, MS 39701 Demographics Map. Title: Sale Brochure

ἇἍἶỼネἿἂὌἯὌἿἛỷンἄἍ株式会社 - Cosmo Oil Company...1 総資ဆ 17,968 16,883 1,085 2 純資ဆ 3,956 3,561 395 3 自 資ஞ 2,750 2,387 363 4 ẇẇ自

the compelling alternative · 2017/18 2018/19 £000s £000s Orbis Operating Budget 16,883 15,923 BHCC Operating Budget 3,757 3,498 20,640 19,420 SCC MoBo Budget 12,513 12,531 ESCC

A new development of high quality trade counter / industrial ......TO LET Available - Spring 2019 from 1,701 sq ft (158 sq m) with combinations up to 20,173 sq ft (1,874 sq m) Gross